Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA)
Running, not enrolling · Not applicable
Conditions studied: Liver Transplantation
In brief
To provide continued access for the LLT system to provide additional safety data in support of the PILOT pivotal efficacy and safety trial
Key facts
- Study ID
- NCT05574361
- Run by
- Organ Recovery Systems, Inc.
- People needed
- 385
- Starts
- 2022-09-19
- Expected to finish
- 2026-10-23
- Last updated by the study team
- 2026-08-03
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may not qualify if…
- Subject is a multi-organ transplant recipient.
- Subject is antibodies blood group (ABO) liver incompatible.
- Subject has severe systemic infection.
- Subject is Human Immunodeficiency Virus (HIV) positive.
- Subject has acute/fulminant liver failure.
- Subject is pregnant.
Where it is running
- Northwestern Memorial Hospital — Chicago, Illinois, United States
- University of Chicago Medical Center — Chicago, Illinois, United States
- Rutgers New Jersey Medical School — Newark, New Jersey, United States
- University of Cincinnati Medical Center — Cincinnati, Ohio, United States
- Intermountain Medical Center — Murray, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.